Re: Farmas USA
Bueno … para mi hoy la pájara que va a tener toooooda mi atención es esta
AMRN
el 26 es su ER y además debe haber un evento justo el fin de semana previo al ER
https://www.lipid.org/springclu
https://www.lipid.org/sites/default/files/files/2019%20NLA%20CLU%20Prospectus.pdf
Everything You Need to Know About Eicosapentaenoic Acid: Its Effects on HDL Functionality and Plaque, Pleiotropic Effects and the Clinical Utility of the EPA/AA Ratio
Speakers: Alan S. Brown, MD, FNLA
Viet Le, MPAS, PA-C, AACC
R. Preston Mason, PhD
John R. Nelson MD, FACC, FNLA, FASNC
Program Overview: Join us for this exciting supplemental CME/CE symposium taking place just three months after the release of the cardiovascular outcomes trial REDUCE-IT results. Our expert faculty will discuss the effects of EPA and provide insights into the future of management of patients with residual risk for atherosclerotic cardiovascular disease.
This is an independent satellite CME/CE symposium held in conjunction with the NLA 2019 Spring Clinical Lipid Update. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.
This activity is supported by educational funding provided by Amarin Pharma Inc.
AKCA
breakout de canal bajista y, lógicamente, primer intento fallido de superación de su MM200 … volverá al ataque pronto ...